A-shares closed · 港股休市 Quotes 行情 · 28 Sep 20:16 CST
29 Sep 2026 · 03:33 CST Terminal Access 终端入口 →
600566.SH上海证券交易所 · 主板 Main

Jumpcan 济川药业

Traditional Chinese Medicine 中药Ⅱ
¥24.66+¥0.25 · +1.02%Delayed 行情延迟 · 28 Sep 2026 · 16:14 CST · CNY
Open 开盘
¥24.42
High 最高
¥24.84
Low 最低
¥24.39
Prev Close 昨收
¥24.41
Volume 成交量
495.0万股
Turnover 成交额
¥1.22亿
Mkt Cap 总市值
¥227亿
P/E 市盈率
12.4×
Recent Activity 近期动态All Filings 全部公告 →

22 significant filings since 1 Jun 2026: 14 on buyback, 4 on equity incentive and 2 on major holder selling, and 1 other kind. The latest, on 25 Sep 2026: 国浩律师(上海)事务所关于济川药业2022 年限制性股票与股票期权激励计划首次授予部分第二个解除限售期解除限售条件及第二个行权期行权条件成就并注销部分股票期权及回购注销部分限制性股票事项之法律意见书.
自 1 Jun 2026 起有 22 份重大公告:buyback 14 份、equity incentive 4 份、major holder selling 2 份,另有 1 类。最新一份(25 Sep 2026):国浩律师(上海)事务所关于济川药业2022 年限制性股票与股票期权激励计划首次授予部分第二个解除限售期解除限售条件及第二个行权期行权条件成就并注销部分股票期权及回购注销部分限制性股票事项之法律意见书。

Price History 价格走势

250 trading days 个交易日 · High 最高 ¥27.47 · Low 最低 ¥22.19
23.0024.0025.0026.0027.00
Volume 成交量
2,341.4万
Sep 25Dec 25Mar 26Jul 26Sep 26
EPS Trend 预测变化
FY2026FY2027
Now 当前2 brokers2 brokers
7 days ago2 brokers2 brokers
30 days ago1 broker1 broker
60 days ago2 brokers2 brokers
90 days ago2 brokers2 brokers

Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数;不足 3 家时显示券商数。

FY2026 Consensus by Month 预测路径
4.151.87

Consensus moved from 4.04 in Sep 2024 to 1.94 in Nov 2025 (-52.0%). 一致预期从 Sep 2024 的 4.04 变为 Nov 2025 的 1.94 (-52.0%)。 The shaded band runs from the lowest to the highest broker forecast.

Revisions 预测调整
FY2026FY2027
Last 30 days▲ 0 ▼ 0 = 2▲ 0 ▼ 0 = 2
Last 90 days▲ 0 ▼ 0 = 2▲ 0 ▼ 0 = 2

Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较,变动在 0.5% 以内视为不变。

Consensus vs Reported 预测与实际

A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0. 惊喜幅度需公告前120天内至少3家券商预测;FY2025仅0家;FY2024仅0家。